Daniel Shao-Weng Tan (Daniel Tan Shao Weng, Daniel S W Tan, Daniel S Tan, Daniel Shao Weng Tan, Daniel Tan, Daniel Sw Tan)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 44

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

National Cancer Centre Singapore

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Centre Singapore May 01 2010

Singapore

Senior Consultant and Principal Investigator :: Medical Oncology

Publications

Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Benjamin J Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel Shao-Weng Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander E Drilon, Philippe Alexandre Cassier
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
See Boon Tay, Guat Hwa Low, Gillian Jing En Wong, Han Jieh Tey, Fun Loon Leong, Constance H Li, Matthew Chin Heng Chua, Daniel Shao-Weng Tan, Choon Hua Thng, Iain Bee Huat Tan, Ryan Shea Ying Cong Tan
Use of Natural Language Processing to Infer Sites of Metastatic Disease From Radiology Reports at Scale. JCO clinical cancer informatics 8 (2024)
Yu Amanda Guo, Tanmay Kulshrestha, Mei Mei Chang, Irfahan Kassam, Egor Revkov, Simone Rizzetto, Aaron C Tan, Daniel Shao-Weng Tan, Iain Beehuat Tan, Anders Jacobsen Skanderup
Transcriptome Deconvolution Reveals Absence of Cancer Cell Expression Signature in Immune Checkpoint Blockade Response. Cancer research communications 4 (6) (2024)
See Boon Tay, Guat Hwa Low, Gillian Jing En Wong, Han Jieh Tey, Fun Loon Leong, Constance H Li, Matthew Chin Heng Chua, Daniel Shao-Weng Tan, Choon Hua Thng, Iain Bee Huat Tan, Ryan Shea Ying Cong Tan
Use of Natural Language Processing to Infer Sites of Metastatic Disease From Radiology Reports at Scale. JCO clinical cancer informatics 8 (2024)
See Boon Tay, Guat Hwa Low, Gillian Jing En Wong, Han Jieh Tey, Fun Loon Leong, Constance H Li, Matthew Chin Heng Chua, Daniel Shao-Weng Tan, Choon Hua Thng, Iain Bee Huat Tan, Ryan Shea Ying Cong Tan
Use of Natural Language Processing to Infer Sites of Metastatic Disease From Radiology Reports at Scale. JCO clinical cancer informatics 8 (2024)
Yi Fei Lee, Cheryl Zi Jin Phua, Ju Yuan, Bin Zhang, May Yin Lee, Srinivasaraghavan Kannan, Yui Hei Jasper Chiu, Casslynn Wei Qian Koh, Choon Kong Yap, Edwin Kok Hao Lim, Jianbin Chen, Yuhua Lim, Jane Jia Hui Lee, Anders Jacobsen Skanderup, Zhenxun Wang, Weiwei Zhai, Nguan Soon Tan, Chandra S Verma, Yvonne Tay, Daniel Shao-Weng Tan, Wai Leong Tam
PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression. Genome medicine 16 (1) (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A phase 1 study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yu Amanda Guo, Tanmay Kulshrestha, Mei Mei Chang, Irfahan Kassam, Egor Revkov, Simone Rizzetto, Aaron C Tan, Daniel Shao-Weng Tan, Iain Beehuat Tan, Anders Jacobsen Skanderup
Transcriptome deconvolution reveals absence of cancer cell expression signature in immune checkpoint blockade response. Cancer research communications (2024)
Yi Fei Lee, Cheryl Zi Jin Phua, Ju Yuan, Bin Zhang, May Yin Lee, Srinivasaraghavan Kannan, Yui Hei Jasper Chiu, Casslynn Wei Qian Koh, Choon Kong Yap, Edwin Kok Hao Lim, Jianbin Chen, Yuhua Lim, Jane Jia Hui Lee, Anders Jacobsen Skanderup, Zhenxun Wang, Weiwei Zhai, Nguan Soon Tan, Chandra S Verma, Yvonne Tay, Daniel Shao-Weng Tan, Wai Leong Tam
PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression. Genome medicine 16 (1) (2024)
Regina Hoo, Kevin L M Chua, Pankaj Kumar Panda, Anders Jacobsen Skanderup, Daniel Shao-Weng Tan
Precision Endpoints for Contemporary Precision Oncology Trials. Cancer discovery 14 (4) (2024)
Thanika Ketpueak, Daniel Shao-Weng Tan, Sanjay Popat
Immunotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: End of the Road or the First Chapter? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Yi Fei Lee, Cheryl Zi Jin Phua, Ju Yuan, Bin Zhang, May Yin Lee, Srinivasaraghavan Kannan, Yui Hei Jasper Chiu, Casslynn Wei Qian Koh, Choon Kong Yap, Edwin Kok Hao Lim, Jianbin Chen, Yuhua Lim, Jane Jia Hui Lee, Anders Jacobsen Skanderup, Zhenxun Wang, Weiwei Zhai, Nguan Soon Tan, Chandra S Verma, Yvonne Tay, Daniel Shao-Weng Tan, Wai Leong Tam
PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression. Genome medicine 16 (1) (2024)
Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Benjamin J Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel Shao-Weng Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander E Drilon, Philippe Alexandre Cassier
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yu Amanda Guo, Tanmay Kulshrestha, Mei Mei Chang, Irfahan Kassam, Egor Revkov, Simone Rizzetto, Aaron C Tan, Daniel Shao-Weng Tan, Iain Beehuat Tan, Anders Jacobsen Skanderup
Transcriptome Deconvolution Reveals Absence of Cancer Cell Expression Signature in Immune Checkpoint Blockade Response. Cancer research communications 4 (6) (2024)
Chen-Yang Huang, Nanhai Jiang, Meixin Shen, Gillianne G Y Lai, Aaron C Tan, Amit Jain, Stephanie P L Saw, Mei Kim Ang, Quan Sing Ng, Darren Wan-Teck Lim, Ravindran Kanesvaran, Eng Huat Tan, Wan Ling Tan, Boon-Hean Ong, Kevin L M Chua, Devanand Anantham, Angela M Takano, Tony Kiat Hon Lim, Wai Leong Tam, Ngak Leng Sim, Anders Jacobsen Skanderup, Daniel Shao-Weng Tan, Steven G Rozen
Oncogene-Driven Non-Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced Mutations. Cancer research 84 (12) (2024)
Chen-Yang Huang, Nanhai Jiang, Meixin Shen, Gillianne G Y Lai, Aaron C Tan, Amit Jain, Stephanie P L Saw, Mei Kim Ang, Quan Sing Ng, Darren Wan-Teck Lim, Ravindran Kanesvaran, Eng Huat Tan, Wan Ling Tan, Boon-Hean Ong, Kevin L M Chua, Devanand Anantham, Angela M Takano, Tony Kiat Hon Lim, Wai Leong Tam, Ngak Leng Sim, Anders Jacobsen Skanderup, Daniel Shao-Weng Tan, Steven G Rozen
Oncogene-driven non-small cell lung cancers in patients with a history of smoking lack smoking-induced mutations. Cancer research (2024)
Yu Amanda Guo, Tanmay Kulshrestha, Mei Mei Chang, Irfahan Kassam, Egor Revkov, Simone Rizzetto, Aaron C Tan, Daniel Shao-Weng Tan, Iain Beehuat Tan, Anders Jacobsen Skanderup
Transcriptome deconvolution reveals absence of cancer cell expression signature in immune checkpoint blockade response. Cancer research communications (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Daniel Shao-Weng Tan, Enriqueta Felip Font, Gilberto de Castro Junior, Benjamin J Solomon, Alastair P Greystoke, Byoung Chul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis G Paz-Ares, Jaafar Bennouna, Marina-Chiara Garassino, Michael Schenker, Sang-We Kim, Jan C Brase, Denise Bury-Maynard, Vanessa Q Passos, Stéphanie Deudon, Bharani Dharan, Yuanbo Song, Rafael Caparica, Bruce E Johnson
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Darren Wan-Teck Lim, Hsiang-Fong Kao, Lisda Suteja, Constance H Li, Hong Sheng Quah, Daniel Shao-Weng Tan, Sze Huey Tan, Eng-Huat Tan, Wan-Ling Tan, Justina Nadia Lee, Felicia Yu-Ting Wee, Amit Jain, Boon-Cher Goh, Matthew Chin Heng Chua, Bin-Chi Liao, Quan Sing Ng, Ruey-Long Hong, Mei-Kim Ang, Joe Poh Sheng Yeong, Narayanan Gopalakrishna Iyer
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma. Nature communications 14 (1) (2023)
Anders Jacobsen Skanderup, Su Fen Ang, Daniel Shao-Weng Tan
Liquid biopsies for cancer genotyping: Coming of age? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sibo Liu, Daniel Shao-Weng Tan, Nicholas Graves, Ann-Marie Chacko
Economic Evaluations of Imaging Biomarker-Driven Companion Diagnostics for Cancer: A Systematic Review. Applied health economics and health policy (2023)
Darren Wan-Teck Lim, Hsiang-Fong Kao, Lisda Suteja, Constance H Li, Hong Sheng Quah, Daniel Shao-Weng Tan, Sze Huey Tan, Eng-Huat Tan, Wan-Ling Tan, Justina Nadia Lee, Felicia Yu-Ting Wee, Amit Jain, Boon-Cher Goh, Matthew Chin Heng Chua, Bin-Chi Liao, Quan Sing Ng, Ruey-Long Hong, Mei-Kim Ang, Joe Poh Sheng Yeong, Narayanan Gopalakrishna Iyer
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma. Nature communications 14 (1) (2023)
Hong Sheng Quah, Elaine Yiqun Cao, Lisda Suteja, Constance H Li, Hui Sun Leong, Fui Teen Chong, Shilpi Gupta, Arcinas Camille Esther Walet, John F Ouyang, Vivian Ang, Teja Celhar, Yunqian Zhao, Hui Chen Tay, Jerry Chan, Takeshi Takahashi, Daniel Shao-Weng Tan, Subhra K Biswas, Owen J L Rackham, Narayanan Gopalakrishna Iyer
Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis. Nature communications 14 (1) (2023)
Sarina Z W Heng, Regina Hoo, Daniel Shao-Weng Tan
Coexisting Genomic Alterations in Risk Stratification of KRASG12C-Mutated Non-Small Cell Lung Cancer. Cancer discovery 13 (7) (2023)
Martin Gutierrez, Wei-Sen Lam, Matthew D Hellmann, Matthew A Gubens, Charu Aggarwal, Daniel Shao-Weng Tan, Enriqueta Felip, Joanne Wing Yan Chiu, Jong-Seok Lee, James Chih-Hsin Yang, Edward B Garon, Giovanna Finocchiaro, Myung-Ju Ahn, Alexander Luft, Gregory A Landers, Andrea Basso, Hua Ma, Julie Kobie, John Palcza, Razvan Cristescu, Lawrence Fong, Alexandra Snyder, Jianda Yuan, Roy S Herbst
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results. Nature medicine (2023)
Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, Alexander I Spira, Ross Andrew Soo, Danny Nguyen, Victor Ho Fun Lee, James Chih-Hsin Yang, Vamsidhar Velcheti, John M Wrangle, Mark A Socinski, Marianna Koczywas, John E Janik, Jeffrey Jones, Helena Alexandra Yu
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hong Sheng Quah, Elaine Yiqun Cao, Lisda Suteja, Constance H Li, Hui Sun Leong, Fui Teen Chong, Shilpi Gupta, Arcinas Camille Esther Walet, John F Ouyang, Vivian Ang, Teja Celhar, Yunqian Zhao, Hui Chen Tay, Jerry Chan, Takeshi Takahashi, Daniel Shao-Weng Tan, Subhra K Biswas, Owen J L Rackham, Narayanan Gopalakrishna Iyer
Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis. Nature communications 14 (1) (2023)
Hong Sheng Quah, Elaine Yiqun Cao, Lisda Suteja, Constance H Li, Hui Sun Leong, Fui Teen Chong, Shilpi Gupta, Arcinas Camille Esther Walet, John F Ouyang, Vivian Ang, Teja Celhar, Yunqian Zhao, Hui Chen Tay, Jerry Chan, Takeshi Takahashi, Daniel Shao-Weng Tan, Subhra K Biswas, Owen J L Rackham, Narayanan Gopalakrishna Iyer
Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis. Nature communications 14 (1) (2023)
Aaron C Tan, Daniel Shao-Weng Tan
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (6) (2022)
Christian Caglevic, Christian D Rolfo, Ignacio Gil-Bazo, Andrés Felipe Cardona, Jorge Sapunar, Fred R Hirsch, David R Gandara, Gilberto Morgan, Silvia Novello, Marina-Chiara Garassino, Giannis S Mountzios, Natasha B Leighl, Denisse Bretel, Arrieta Oscar, Alfredo Addeo, Stephen V Liu, Luis Corrales-Rodríguez, Vivek Subbiah, Francisco Aboitiz, Franz Villaroel-Espindola, Felipe Reyes-Cosmelli, Ricardo Morales, Mauricio Mahave, Luis Raez, Jorge Alatorre, Edgardo S Santos, Luis Ubillos, Daniel Shao-Weng Tan, Christoph C Zielinski
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations. JCO global oncology 8 (2022)
Tira Jing Ying Tan, J Lynn Fink, Timothy Kwang Yong Tay, Binny Jaradi, Nathan Stone, Paul M Waring, Kevin M Koo, Puay Hoon Tan, Daniel Shao-Weng Tan, Rebecca A Dent
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for BRCA Methylation Testing? JCO precision oncology 6 (2022)
Alexander E Drilon, Daniel Shao-Weng Tan, Ulrik N Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D Patel, Lee S Rosen, Benjamin Solomon, Ricarda Norenberg, Laura Dima, Nicoletta Brega, Lin Shen, Victor Moreno, Shivaani Kummar, Jessica J Lin
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers. JCO precision oncology 6 (2022)
Jonathan Soon Jian Hao, Chan Sock Hoai, Daniel Shao-Weng Tan, Joanne Ngeow Yuen Yie, Jianbang Chiang
Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant. Cold Spring Harbor molecular case studies 8 (7) (2022)
Stephanie Pl Saw, Mei-Kim Ang, Daniel Shao-Weng Tan
Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions. Current treatment options in oncology (2022)
Aaron C Tan, Stephanie P L Saw, Jianbin Chen, Gillianne G Y Lai, Hlaing Nwe Oo, Angela Takano, Dawn P X Lau, Joe P S Yeong, Gek San Tan, Tony Kiat Hon Lim, Anders Jacobsen Skanderup, Johan W K Chan, Yi Lin Teh, Tanujaa Rajasekaran, Amit Jain, Wan Ling Tan, Quan Sing Ng, Ravindran Kanesvaran, Darren Wan-Teck Lim, Mei-Kim Ang, Daniel Shao-Weng Tan
Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer. JCO precision oncology 6 (2022)
Jonathan Soon Jian Hao, Chan Sock Hoai, Daniel Shao-Weng Tan, Joanne Ngeow Yuen Yie, Jianbang Chiang
Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant. Cold Spring Harbor molecular case studies 8 (7) (2022)
Alexander E Drilon, Vivek Subbiah, Oliver Gautschi, Pascale Tomasini, Filippo de Braud, Benjamin J Solomon, Daniel Shao-Weng Tan, Guzmán Alonso, Juergen Wolf, Keunchil Park, Koichi Goto, Victoria Soldatenkova, Sylwia Szymczak, Scott S Barker, Tarun Puri, Aimee Bence Lin, Herbert Ho-Fung Loong, Benjamin Besse
Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jonathan Soon Jian Hao, Chan Sock Hoai, Daniel Shao-Weng Tan, Joanne Ngeow Yuen Yie, Jianbang Chiang
Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant. Cold Spring Harbor molecular case studies 8 (7) (2022)
Jonathan Soon Jian Hao, Chan Sock Hoai, Daniel Shao-Weng Tan, Joanne Ngeow Yuen Yie, Jianbang Chiang
Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant. Cold Spring Harbor molecular case studies 8 (7) (2022)
Aaron C Tan, Tracy J Loh, Xue Lin Kwang, Gek San Tan, Kiat Hon Lim, Daniel Shao-Weng Tan
Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib. Lung Cancer (Auckland, N.Z.) 12 (2021)
Egbert F Smit, Christophe Dooms, Jo Raskin, Ernest Nadal, Lye M Tho, Xiuning Li, Julien Mazieres, Soon Hin How, Masahiro Morise, Viola W Zhu, Daniel Shao-Weng Tan, Kristina H Holmberg, Barbara Ellers-Lenz, Svenja Adrian, Sabine Brutlach, Karl M Schumacher, Niki Karachaliou, Yi-Long Wu
INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET -amplified NSCLC and first-line osimertinib resistance. Future oncology (London, England) 18 (9) (2021)
Jianbin Chen, Hechuan Yang, Audrey Su Min Teo, Lidyana Bte Amer, Faranak Ghazi Sherbaf, Chu Quan Tan, Jacob Josiah Santiago Alvarez, Bingxin Lu, Jia Qi Lim, Angela Takano, Rahul Nahar, Yin Yeng Lee, Cheryl Zi Jin Phua, Khi Pin Chua, Lisda Suteja, Pauline Jieqi Chen, Mei Mei Chang, Tina Puay Theng Koh, Boon-Hean Ong, Devanand Anantham, Anne Ann Ling Hsu, Apoorva Gogna, Chow Wei Too, Zaw Win Aung, Yi Fei Lee, Lanying Wang, Tony Kiat Hon Lim, Andreas Wilm, Poh Sum Choi, Poh Yong Ng, Chee Keong Toh, Wan-Teck Lim, Siming Ma, Bing Lim, Jin Liu, Wai Leong Tam, Anders Jacobsen Skanderup, Joe Poh Sheng Yeong, Eng-Huat Tan, Caretha L Creasy, Daniel Shao-Weng Tan, Axel Maximilian Hillmer, Weiwei Zhai
Genomic landscape of lung adenocarcinoma in East Asians. Nature genetics 52 (2) (2020)

Daniel Shao-Weng Tan.css-eqlu8i{font-size:small;padding-left:4px;} (Daniel Tan Shao Weng, Daniel S W Tan, Daniel S Tan, Daniel Shao Weng Tan, Daniel Tan, Daniel Sw Tan)

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Shao-Weng Tan (Daniel Tan Shao Weng, Daniel S W Tan, Daniel S Tan, Daniel Shao Weng Tan, Daniel Tan, Daniel Sw Tan)